Improving prostate cancer monitoring | Large public university hospital
Supporting proactive prostate cancer monitoring through AI-powered clinical follow-up

Summary
Conversational AI can bring 24/7 availability, quick access to information, greater efficiency and a more personalized experience to the monitoring of prostate cancer patients. This story presents the initial experience with LOLA at Hospital Universitario de Getafe. From January to October 2024, 131 prostate cancer patients were enrolled. LOLA conducted quarterly calls collecting general well-being, fractures and falls, urinary symptoms, fever and pain, as well as PSA values and the next appointment date, and alerted clinicians to clinical changes.
-2.png)